JP2014510708A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014510708A5 JP2014510708A5 JP2013547047A JP2013547047A JP2014510708A5 JP 2014510708 A5 JP2014510708 A5 JP 2014510708A5 JP 2013547047 A JP2013547047 A JP 2013547047A JP 2013547047 A JP2013547047 A JP 2013547047A JP 2014510708 A5 JP2014510708 A5 JP 2014510708A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- optionally substituted
- oxadiazol
- fluoro
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000005843 halogen group Chemical group 0.000 claims 34
- 125000004093 cyano group Chemical group *C#N 0.000 claims 30
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 30
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims 29
- 125000003118 aryl group Chemical group 0.000 claims 29
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 28
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 28
- 125000001072 heteroaryl group Chemical group 0.000 claims 26
- 125000003545 alkoxy group Chemical group 0.000 claims 25
- 125000001424 substituent group Chemical group 0.000 claims 25
- 125000002950 monocyclic group Chemical group 0.000 claims 22
- 125000002619 bicyclic group Chemical group 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 20
- 150000003839 salts Chemical class 0.000 claims 20
- 125000000623 heterocyclic group Chemical group 0.000 claims 19
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 19
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 18
- 125000000081 (C5-C8) cycloalkenyl group Chemical group 0.000 claims 18
- 125000002252 acyl group Chemical group 0.000 claims 18
- 125000004043 oxo group Chemical group O=* 0.000 claims 18
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 17
- 229910052757 nitrogen Inorganic materials 0.000 claims 17
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 16
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 15
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 14
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 12
- 125000003342 alkenyl group Chemical group 0.000 claims 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 12
- 125000000304 alkynyl group Chemical group 0.000 claims 11
- 125000003277 amino group Chemical group 0.000 claims 11
- -1 phenacyl group Chemical group 0.000 claims 11
- 125000004430 oxygen atom Chemical group O* 0.000 claims 10
- 125000004104 aryloxy group Chemical group 0.000 claims 9
- 229910052799 carbon Inorganic materials 0.000 claims 8
- 125000004432 carbon atom Chemical group C* 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 125000005842 heteroatom Chemical group 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 229920006395 saturated elastomer Polymers 0.000 claims 6
- 125000003107 substituted aryl group Chemical group 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 125000004434 sulfur atom Chemical group 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 3
- NYCVCXMSZNOGDH-UHFFFAOYSA-N pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1 NYCVCXMSZNOGDH-UHFFFAOYSA-N 0.000 claims 3
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 2
- OESVOUZRYHMLHI-UHFFFAOYSA-N 1-[4-[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]-4-methylpiperidin-1-yl]-2-methoxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C1(C)CCN(C(=O)COC)CC1 OESVOUZRYHMLHI-UHFFFAOYSA-N 0.000 claims 2
- HWKVHAKGQAKPSQ-UHFFFAOYSA-N 1-[4-[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]piperidin-1-yl]-2-methoxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C1CCN(C(=O)COC)CC1 HWKVHAKGQAKPSQ-UHFFFAOYSA-N 0.000 claims 2
- MUMXSJKRTMAHIN-UHFFFAOYSA-N 1-[4-[4-[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]piperidin-1-yl]-2-hydroxyethanone Chemical compound C12=C(F)C=CC=C2C(C(C)C)=NN1C(N=1)=NOC=1C(CC1)CCN1C1CCN(C(=O)CO)CC1 MUMXSJKRTMAHIN-UHFFFAOYSA-N 0.000 claims 2
- OXJXZHXXGNJMTA-UHFFFAOYSA-N 1-[4-[4-[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]piperidin-1-yl]-2-methoxyethanone Chemical compound C1CN(C(=O)COC)CCC1N1CCC(C=2ON=C(N=2)N2C3=C(F)C=CC=C3C(C(C)C)=N2)CC1 OXJXZHXXGNJMTA-UHFFFAOYSA-N 0.000 claims 2
- QWAPFRNMUGMNHY-UHFFFAOYSA-N 1-[4-[4-[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]piperidin-1-yl]ethanone Chemical compound C12=C(F)C=CC=C2C(C(C)C)=NN1C(N=1)=NOC=1C(CC1)CCN1C1CCN(C(C)=O)CC1 QWAPFRNMUGMNHY-UHFFFAOYSA-N 0.000 claims 2
- ANJNIJQFOWNGMN-UHFFFAOYSA-N 3-(3-ethylindazol-1-yl)-5-[1-(2-methylpropyl)piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=CC=CC=C2C(CC)=NN1C(N=1)=NOC=1C1CCN(CC(C)C)CC1 ANJNIJQFOWNGMN-UHFFFAOYSA-N 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- BFGQFILTMVCOFW-INIZCTEOSA-N (2s)-1-[4-[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]-4-methylpiperidin-1-yl]-2-hydroxypropan-1-one Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C1(C)CCN(C(=O)[C@H](C)O)CC1 BFGQFILTMVCOFW-INIZCTEOSA-N 0.000 claims 1
- MBHLLEMPOJORAC-DLBZAZTESA-N 1-[(2r)-2-[[(3s)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]pyrrolidin-1-yl]-2-hydroxyethanone Chemical compound C([C@H](C1)CC=2ON=C(N=2)N2N=C(C3=CC=CC(F)=C32)C(C)C)CN1C[C@H]1CCCN1C(=O)CO MBHLLEMPOJORAC-DLBZAZTESA-N 0.000 claims 1
- QIDVQLREYCHXBT-QGZVFWFLSA-N 1-[(2r)-2-[[4-[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]-2-hydroxyethanone Chemical compound C12=C(F)C=CC=C2C(C(C)C)=NN1C(N=1)=NOC=1C(CC1)CCN1C[C@H]1CCCN1C(=O)CO QIDVQLREYCHXBT-QGZVFWFLSA-N 0.000 claims 1
- MBHLLEMPOJORAC-IRXDYDNUSA-N 1-[(2s)-2-[[(3s)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]pyrrolidin-1-yl]-2-hydroxyethanone Chemical compound C([C@H](C1)CC=2ON=C(N=2)N2N=C(C3=CC=CC(F)=C32)C(C)C)CN1C[C@@H]1CCCN1C(=O)CO MBHLLEMPOJORAC-IRXDYDNUSA-N 0.000 claims 1
- VRQZMCLLJRPDFX-INIZCTEOSA-N 1-[(2s)-2-[[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]-2-hydroxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C[C@@H]1CCCN1C(=O)CO VRQZMCLLJRPDFX-INIZCTEOSA-N 0.000 claims 1
- CUDONWZUXRTGLR-IAGOWNOFSA-N 1-[(3r)-3-[[(3r)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]pyrrolidin-1-yl]-2-hydroxyethanone Chemical compound C([C@@H](C1)CC=2ON=C(N=2)N2N=C(C3=CC=CC(F)=C32)C(C)C)CN1C[C@H]1CCN(C(=O)CO)C1 CUDONWZUXRTGLR-IAGOWNOFSA-N 0.000 claims 1
- HGZOAZODDJVYTO-QZTJIDSGSA-N 1-[(3r)-3-[[(3r)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]pyrrolidin-1-yl]-2-methoxyethanone Chemical compound C1N(C(=O)COC)CC[C@@H]1CN1C[C@@H](CC=2ON=C(N=2)N2C3=C(F)C=CC=C3C(C(C)C)=N2)CC1 HGZOAZODDJVYTO-QZTJIDSGSA-N 0.000 claims 1
- CUDONWZUXRTGLR-DLBZAZTESA-N 1-[(3r)-3-[[(3s)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]pyrrolidin-1-yl]-2-hydroxyethanone Chemical compound C([C@H](C1)CC=2ON=C(N=2)N2N=C(C3=CC=CC(F)=C32)C(C)C)CN1C[C@H]1CCN(C(=O)CO)C1 CUDONWZUXRTGLR-DLBZAZTESA-N 0.000 claims 1
- DBPUJDHYTDWYKN-OAHLLOKOSA-N 1-[(3r)-3-[[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]-2-hydroxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C[C@H]1CCN(C(=O)CO)C1 DBPUJDHYTDWYKN-OAHLLOKOSA-N 0.000 claims 1
- OEQYNZXSMQIWST-MRXNPFEDSA-N 1-[(3r)-3-[[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]-2-methoxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C[C@H]1CCN(C(=O)COC)C1 OEQYNZXSMQIWST-MRXNPFEDSA-N 0.000 claims 1
- KSHNUMSXRLBXDI-MRXNPFEDSA-N 1-[(3r)-3-[[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]ethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C[C@H]1CCN(C(C)=O)C1 KSHNUMSXRLBXDI-MRXNPFEDSA-N 0.000 claims 1
- HGZOAZODDJVYTO-MSOLQXFVSA-N 1-[(3s)-3-[[(3r)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]pyrrolidin-1-yl]-2-methoxyethanone Chemical compound C1N(C(=O)COC)CC[C@H]1CN1C[C@@H](CC=2ON=C(N=2)N2C3=C(F)C=CC=C3C(C(C)C)=N2)CC1 HGZOAZODDJVYTO-MSOLQXFVSA-N 0.000 claims 1
- NWJMYBCZZZLUFH-MSOLQXFVSA-N 1-[(3s)-3-[[(3r)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]pyrrolidin-1-yl]ethanone Chemical compound C([C@@H](C1)CC=2ON=C(N=2)N2N=C(C3=CC=CC(F)=C32)C(C)C)CN1C[C@@H]1CCN(C(C)=O)C1 NWJMYBCZZZLUFH-MSOLQXFVSA-N 0.000 claims 1
- CUDONWZUXRTGLR-IRXDYDNUSA-N 1-[(3s)-3-[[(3s)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]pyrrolidin-1-yl]-2-hydroxyethanone Chemical compound C([C@H](C1)CC=2ON=C(N=2)N2N=C(C3=CC=CC(F)=C32)C(C)C)CN1C[C@@H]1CCN(C(=O)CO)C1 CUDONWZUXRTGLR-IRXDYDNUSA-N 0.000 claims 1
- HGZOAZODDJVYTO-ROUUACIJSA-N 1-[(3s)-3-[[(3s)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]pyrrolidin-1-yl]-2-methoxyethanone Chemical compound C1N(C(=O)COC)CC[C@H]1CN1C[C@H](CC=2ON=C(N=2)N2C3=C(F)C=CC=C3C(C(C)C)=N2)CC1 HGZOAZODDJVYTO-ROUUACIJSA-N 0.000 claims 1
- DBPUJDHYTDWYKN-HNNXBMFYSA-N 1-[(3s)-3-[[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]-2-hydroxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C[C@@H]1CCN(C(=O)CO)C1 DBPUJDHYTDWYKN-HNNXBMFYSA-N 0.000 claims 1
- OEQYNZXSMQIWST-INIZCTEOSA-N 1-[(3s)-3-[[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]-2-methoxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C[C@@H]1CCN(C(=O)COC)C1 OEQYNZXSMQIWST-INIZCTEOSA-N 0.000 claims 1
- KSHNUMSXRLBXDI-INIZCTEOSA-N 1-[(3s)-3-[[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]ethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C[C@@H]1CCN(C(C)=O)C1 KSHNUMSXRLBXDI-INIZCTEOSA-N 0.000 claims 1
- OUFSOXKXMOXXLL-OAHLLOKOSA-N 1-[3-[[(3r)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]azetidin-1-yl]-2-hydroxyethanone Chemical compound C([C@@H](C1)CC=2ON=C(N=2)N2N=C(C3=CC=CC(F)=C32)C(C)C)CN1CC1CN(C(=O)CO)C1 OUFSOXKXMOXXLL-OAHLLOKOSA-N 0.000 claims 1
- RLZYHVVQPIAASE-MRXNPFEDSA-N 1-[3-[[(3r)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]azetidin-1-yl]-2-methoxyethanone Chemical compound C1N(C(=O)COC)CC1CN1C[C@@H](CC=2ON=C(N=2)N2C3=C(F)C=CC=C3C(C(C)C)=N2)CC1 RLZYHVVQPIAASE-MRXNPFEDSA-N 0.000 claims 1
- PFDBLDXPCWBDIO-MRXNPFEDSA-N 1-[3-[[(3r)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]azetidin-1-yl]ethanone Chemical compound C([C@@H](C1)CC=2ON=C(N=2)N2N=C(C3=CC=CC(F)=C32)C(C)C)CN1CC1CN(C(C)=O)C1 PFDBLDXPCWBDIO-MRXNPFEDSA-N 0.000 claims 1
- RLZYHVVQPIAASE-INIZCTEOSA-N 1-[3-[[(3s)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]methyl]azetidin-1-yl]-2-methoxyethanone Chemical compound C1N(C(=O)COC)CC1CN1C[C@H](CC=2ON=C(N=2)N2C3=C(F)C=CC=C3C(C(C)C)=N2)CC1 RLZYHVVQPIAASE-INIZCTEOSA-N 0.000 claims 1
- BAJCMSHWHVWULL-UHFFFAOYSA-N 1-[3-[[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]azetidin-1-yl]-2-hydroxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1CC1CN(C(=O)CO)C1 BAJCMSHWHVWULL-UHFFFAOYSA-N 0.000 claims 1
- BQPBKRHIEZFMSQ-UHFFFAOYSA-N 1-[3-[[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]azetidin-1-yl]-2-methoxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1CC1CN(C(=O)COC)C1 BQPBKRHIEZFMSQ-UHFFFAOYSA-N 0.000 claims 1
- ZWYWLDXUNIOMHJ-UHFFFAOYSA-N 1-[3-[[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]azetidin-1-yl]ethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1CC1CN(C(C)=O)C1 ZWYWLDXUNIOMHJ-UHFFFAOYSA-N 0.000 claims 1
- LWJGQBHNVKVSHJ-UHFFFAOYSA-N 1-[3-[[4-[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]azetidin-1-yl]-2-methoxyethanone Chemical compound C1N(C(=O)COC)CC1CN1CCC(C=2ON=C(N=2)N2C3=C(F)C=CC=C3C(C(C)C)=N2)CC1 LWJGQBHNVKVSHJ-UHFFFAOYSA-N 0.000 claims 1
- JXNJLEXUJPZADT-UHFFFAOYSA-N 1-[3-[[4-[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]azetidin-1-yl]ethanone Chemical compound C12=C(F)C=CC=C2C(C(C)C)=NN1C(N=1)=NOC=1C(CC1)CCN1CC1CN(C(C)=O)C1 JXNJLEXUJPZADT-UHFFFAOYSA-N 0.000 claims 1
- OOYQGQXAIOWLDW-QGZVFWFLSA-N 1-[4-[(3r)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]piperidin-1-yl]-2-methoxyethanone Chemical compound C1CN(C(=O)COC)CCC1N1C[C@@H](CC=2ON=C(N=2)N2C3=C(F)C=CC=C3C(C(C)C)=N2)CC1 OOYQGQXAIOWLDW-QGZVFWFLSA-N 0.000 claims 1
- NIBZFXWOZKSFIT-INIZCTEOSA-N 1-[4-[(3s)-3-[[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]piperidin-1-yl]ethanone Chemical compound C([C@H](C1)CC=2ON=C(N=2)N2N=C(C3=CC=CC(F)=C32)CC)CN1C1CCN(C(C)=O)CC1 NIBZFXWOZKSFIT-INIZCTEOSA-N 0.000 claims 1
- OOYQGQXAIOWLDW-KRWDZBQOSA-N 1-[4-[(3s)-3-[[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]methyl]pyrrolidin-1-yl]piperidin-1-yl]-2-methoxyethanone Chemical compound C1CN(C(=O)COC)CCC1N1C[C@H](CC=2ON=C(N=2)N2C3=C(F)C=CC=C3C(C(C)C)=N2)CC1 OOYQGQXAIOWLDW-KRWDZBQOSA-N 0.000 claims 1
- IBZXBKUUTRWKLC-UHFFFAOYSA-N 1-[4-[4-[3-(3-ethyl-6-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]piperidin-1-yl]ethanone Chemical compound C12=CC(F)=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C1CCN(C(C)=O)CC1 IBZXBKUUTRWKLC-UHFFFAOYSA-N 0.000 claims 1
- RAVCNWHAZVFEIU-UHFFFAOYSA-N 1-[4-[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]-4-methylpiperidin-1-yl]-2-hydroxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C1(C)CCN(C(=O)CO)CC1 RAVCNWHAZVFEIU-UHFFFAOYSA-N 0.000 claims 1
- QSLDCXZFUZFZCZ-UHFFFAOYSA-N 1-[4-[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]piperidin-1-yl]-2-hydroxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C1CCN(C(=O)CO)CC1 QSLDCXZFUZFZCZ-UHFFFAOYSA-N 0.000 claims 1
- PUMGOQSFPDZFCT-UHFFFAOYSA-N 1-[4-[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]piperidin-1-yl]ethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C1CCN(C(C)=O)CC1 PUMGOQSFPDZFCT-UHFFFAOYSA-N 0.000 claims 1
- AZHYXQUMPRMIPP-UHFFFAOYSA-N 1-[4-[4-[3-(7-fluoro-3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]-3-methylpiperidin-1-yl]-2-hydroxyethanone Chemical compound C12=C(F)C=CC=C2C(C(C)C)=NN1C(N=1)=NOC=1C(CC1)CCN1C1CCN(C(=O)CO)CC1C AZHYXQUMPRMIPP-UHFFFAOYSA-N 0.000 claims 1
- KSRNURQSWQDXOM-UHFFFAOYSA-N 1-[4-[[4-[3-(3-ethyl-7-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methyl]piperidin-1-yl]-2-hydroxyethanone Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1CC1CCN(C(=O)CO)CC1 KSRNURQSWQDXOM-UHFFFAOYSA-N 0.000 claims 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims 1
- LSSGAMFKGPXTSG-UHFFFAOYSA-N 3-(3-cyclobutylindazol-1-yl)-5-[1-(2-methylpropyl)piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C1CN(CC(C)C)CCC1C1=NC(N2C3=CC=CC=C3C(C3CCC3)=N2)=NO1 LSSGAMFKGPXTSG-UHFFFAOYSA-N 0.000 claims 1
- UPEWACUKDKPZFZ-UHFFFAOYSA-N 3-(3-cyclopropylindazol-1-yl)-5-[1-(3-methoxypropyl)piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C1CN(CCCOC)CCC1C1=NC(N2C3=CC=CC=C3C(C3CC3)=N2)=NO1 UPEWACUKDKPZFZ-UHFFFAOYSA-N 0.000 claims 1
- HOTSKDJTIYFOFX-UHFFFAOYSA-N 3-(3-ethyl-6-fluoroindazol-1-yl)-5-(1-propan-2-ylpiperidin-4-yl)-1,2,4-oxadiazole Chemical compound C12=CC(F)=CC=C2C(CC)=NN1C(N=1)=NOC=1C1CCN(C(C)C)CC1 HOTSKDJTIYFOFX-UHFFFAOYSA-N 0.000 claims 1
- KVMDFFICDUBQIA-UHFFFAOYSA-N 3-(3-ethyl-6-fluoroindazol-1-yl)-5-[1-(3-methoxypropyl)piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=CC(F)=CC=C2C(CC)=NN1C(N=1)=NOC=1C1CCN(CCCOC)CC1 KVMDFFICDUBQIA-UHFFFAOYSA-N 0.000 claims 1
- XYXXNTSJPOTJPD-UHFFFAOYSA-N 3-(3-ethyl-6-fluoroindazol-1-yl)-5-[1-(oxan-4-ylmethyl)piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=CC(F)=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1CC1CCOCC1 XYXXNTSJPOTJPD-UHFFFAOYSA-N 0.000 claims 1
- SIUIIWXMVCWPFU-UHFFFAOYSA-N 3-(3-ethyl-6-fluoroindazol-1-yl)-5-[1-(oxolan-3-yl)piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=CC(F)=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C1CCOC1 SIUIIWXMVCWPFU-UHFFFAOYSA-N 0.000 claims 1
- GHTJFFIPTCBHEG-UHFFFAOYSA-N 3-(3-ethyl-6-fluoroindazol-1-yl)-5-[1-[2-(oxan-4-yl)ethyl]piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=CC(F)=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1CCC1CCOCC1 GHTJFFIPTCBHEG-UHFFFAOYSA-N 0.000 claims 1
- GKWJZAWUHKCMAR-UHFFFAOYSA-N 3-(3-ethyl-6-fluoroindazol-1-yl)-5-[1-[2-(oxolan-2-yl)ethyl]piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=CC(F)=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1CCC1CCCO1 GKWJZAWUHKCMAR-UHFFFAOYSA-N 0.000 claims 1
- CWNNWNSVQQXMIM-UHFFFAOYSA-N 3-(3-ethyl-7-fluoroindazol-1-yl)-5-[1-(1-methylsulfonylpiperidin-4-yl)piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C1CCN(S(C)(=O)=O)CC1 CWNNWNSVQQXMIM-UHFFFAOYSA-N 0.000 claims 1
- QNWXFSNRRTYHBM-UHFFFAOYSA-N 3-(3-ethyl-7-fluoroindazol-1-yl)-5-[1-(3-methoxypropyl)piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C1CCN(CCCOC)CC1 QNWXFSNRRTYHBM-UHFFFAOYSA-N 0.000 claims 1
- PBFWIRJENZTYLS-OAHLLOKOSA-N 3-(3-ethyl-7-fluoroindazol-1-yl)-5-[1-[[(3r)-1-methylsulfonylpyrrolidin-3-yl]methyl]piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C[C@H]1CCN(S(C)(=O)=O)C1 PBFWIRJENZTYLS-OAHLLOKOSA-N 0.000 claims 1
- PBFWIRJENZTYLS-HNNXBMFYSA-N 3-(3-ethyl-7-fluoroindazol-1-yl)-5-[1-[[(3s)-1-methylsulfonylpyrrolidin-3-yl]methyl]piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=C(F)C=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C[C@@H]1CCN(S(C)(=O)=O)C1 PBFWIRJENZTYLS-HNNXBMFYSA-N 0.000 claims 1
- QDGPBSMDNXXFIY-UHFFFAOYSA-N 3-(3-ethylindazol-1-yl)-5-[1-(3-methoxypropyl)piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=CC=CC=C2C(CC)=NN1C(N=1)=NOC=1C1CCN(CCCOC)CC1 QDGPBSMDNXXFIY-UHFFFAOYSA-N 0.000 claims 1
- IHAYQKGJNWCNNG-UHFFFAOYSA-N 3-(3-ethylindazol-1-yl)-5-[1-(oxolan-2-ylmethyl)piperidin-4-yl]-1,2,4-oxadiazole Chemical compound C12=CC=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1CC1CCCO1 IHAYQKGJNWCNNG-UHFFFAOYSA-N 0.000 claims 1
- VXZCTHDZGQPRNB-UHFFFAOYSA-N 3-(3-propan-2-ylindazol-1-yl)-5-(1-propylpiperidin-4-yl)-1,2,4-oxadiazole Chemical compound C1CN(CCC)CCC1C1=NC(N2C3=CC=CC=C3C(C(C)C)=N2)=NO1 VXZCTHDZGQPRNB-UHFFFAOYSA-N 0.000 claims 1
- BWNJKRFSQWSCLZ-UHFFFAOYSA-N 3-[4-[3-(3-ethylindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]propan-1-ol Chemical compound C12=CC=CC=C2C(CC)=NN1C(N=1)=NOC=1C1CCN(CCCO)CC1 BWNJKRFSQWSCLZ-UHFFFAOYSA-N 0.000 claims 1
- YVYFLKAXFQVCCC-UHFFFAOYSA-N 5-(1-butan-2-ylpiperidin-4-yl)-3-(3-cyclobutylindazol-1-yl)-1,2,4-oxadiazole Chemical compound C1CN(C(C)CC)CCC1C1=NC(N2C3=CC=CC=C3C(C3CCC3)=N2)=NO1 YVYFLKAXFQVCCC-UHFFFAOYSA-N 0.000 claims 1
- UFPZJYAJNHUFSS-UHFFFAOYSA-N 5-(1-butan-2-ylpiperidin-4-yl)-3-(3-cyclopropylindazol-1-yl)-1,2,4-oxadiazole Chemical compound C1CN(C(C)CC)CCC1C1=NC(N2C3=CC=CC=C3C(C3CC3)=N2)=NO1 UFPZJYAJNHUFSS-UHFFFAOYSA-N 0.000 claims 1
- XWBWURBJEPTIHV-UHFFFAOYSA-N 5-(1-butan-2-ylpiperidin-4-yl)-3-(3-ethylindazol-1-yl)-1,2,4-oxadiazole Chemical compound C1CN(C(C)CC)CCC1C1=NC(N2C3=CC=CC=C3C(CC)=N2)=NO1 XWBWURBJEPTIHV-UHFFFAOYSA-N 0.000 claims 1
- PTCUXBSTCRMCOY-UHFFFAOYSA-N 5-[1-(2-methylpropyl)piperidin-4-yl]-3-(3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazole Chemical compound C1CN(CC(C)C)CCC1C1=NC(N2C3=CC=CC=C3C(C(C)C)=N2)=NO1 PTCUXBSTCRMCOY-UHFFFAOYSA-N 0.000 claims 1
- ZSFAZNJBEGJGAS-UHFFFAOYSA-N 5-[1-(3-methoxypropyl)piperidin-4-yl]-3-(3-propan-2-ylindazol-1-yl)-1,2,4-oxadiazole Chemical compound C1CN(CCCOC)CCC1C1=NC(N2C3=CC=CC=C3C(C(C)C)=N2)=NO1 ZSFAZNJBEGJGAS-UHFFFAOYSA-N 0.000 claims 1
- DYXGXIBMYYSRTE-UHFFFAOYSA-N 5-[1-(cyclopropylmethyl)piperidin-4-yl]-3-(3-ethylindazol-1-yl)-1,2,4-oxadiazole Chemical compound C12=CC=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1CC1CC1 DYXGXIBMYYSRTE-UHFFFAOYSA-N 0.000 claims 1
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 claims 1
- KVVMXWRFYAGASO-UHFFFAOYSA-N azetidine-1-carboxylic acid Chemical compound OC(=O)N1CCC1 KVVMXWRFYAGASO-UHFFFAOYSA-N 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 125000004438 haloalkoxy group Chemical group 0.000 claims 1
- 125000001188 haloalkyl group Chemical group 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- KHTBKDIVMIHRSN-UHFFFAOYSA-N methyl 4-[4-[3-(3-ethyl-6-fluoroindazol-1-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]piperidine-1-carboxylate Chemical compound C12=CC(F)=CC=C2C(CC)=NN1C(N=1)=NOC=1C(CC1)CCN1C1CCN(C(=O)OC)CC1 KHTBKDIVMIHRSN-UHFFFAOYSA-N 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 claims 1
- 150000003413 spiro compounds Chemical class 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013547047A JP2014510708A (ja) | 2011-06-07 | 2012-06-06 | インダゾール誘導体およびピロロピリジン誘導体ならびにその医薬用途 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011127688 | 2011-06-07 | ||
| JP2011127688 | 2011-06-07 | ||
| JP2013547047A JP2014510708A (ja) | 2011-06-07 | 2012-06-06 | インダゾール誘導体およびピロロピリジン誘導体ならびにその医薬用途 |
| PCT/JP2012/065052 WO2012169649A1 (en) | 2011-06-07 | 2012-06-06 | Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014510708A JP2014510708A (ja) | 2014-05-01 |
| JP2014510708A5 true JP2014510708A5 (enExample) | 2014-06-19 |
Family
ID=47296200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013547047A Pending JP2014510708A (ja) | 2011-06-07 | 2012-06-06 | インダゾール誘導体およびピロロピリジン誘導体ならびにその医薬用途 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20140057895A1 (enExample) |
| EP (1) | EP2718283A4 (enExample) |
| JP (1) | JP2014510708A (enExample) |
| KR (1) | KR20140041519A (enExample) |
| CN (1) | CN103748087A (enExample) |
| AU (1) | AU2012267797A1 (enExample) |
| BR (1) | BR112013030939A2 (enExample) |
| CA (1) | CA2833507A1 (enExample) |
| MX (1) | MX2013014427A (enExample) |
| RU (1) | RU2013157374A (enExample) |
| TW (1) | TW201311674A (enExample) |
| WO (1) | WO2012169649A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016028016A (ja) * | 2012-12-12 | 2016-02-25 | 大日本住友製薬株式会社 | オキサジアゾール誘導体とその医薬用途 |
| EA027879B1 (ru) | 2013-02-22 | 2017-09-29 | Пфайзер Инк. | ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-РОДСТВЕННЫХ КИНАЗ (JAK) |
| WO2016024185A1 (en) | 2014-08-12 | 2016-02-18 | Pfizer Inc. | Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase |
| JOP20190024A1 (ar) | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | مركبات بيروليزين بها استبدال واستخداماتها |
| KR102140508B1 (ko) | 2016-09-28 | 2020-08-03 | 경희대학교 산학협력단 | 헌팅턴병의 예방 또는 치료용 조성물 |
| EP3529245A4 (en) * | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THE LATEST |
| MA47212A (fr) | 2017-01-06 | 2019-11-13 | Yumanity Therapeutics Inc | Méthodes de traitement de troubles neurologiques |
| WO2019084157A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES THEREOF |
| JP7050165B2 (ja) | 2018-02-26 | 2022-04-07 | ギリアード サイエンシーズ， インコーポレイテッド | Ｈｂｖ複製阻害剤としての置換ピロリジン化合物 |
| ES3043183T3 (en) | 2018-03-23 | 2025-11-25 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| MA54829A (fr) | 2019-01-24 | 2021-12-01 | Yumanity Therapeutics Inc | Composés et leurs utilisations |
| US12590083B2 (en) * | 2019-01-25 | 2026-03-31 | University Of Virginia Patent Foundation | Inhibitors of spinster homolog 2 (SPNS2) for use in therapy |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
| EP4178955A1 (en) | 2020-07-11 | 2023-05-17 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| CN116836157A (zh) * | 2022-03-25 | 2023-10-03 | 星希尔生物科技(上海)有限公司 | 一种噁二唑衍生物及其制备方法和用途 |
| CN115417772B (zh) * | 2022-09-26 | 2024-07-19 | 无锡双启科技有限公司 | 一种3-硝基-4-氟苯甲醚的制备方法 |
| CN115947690B (zh) * | 2022-12-13 | 2025-04-08 | 安徽医科大学 | 一种吲唑分子砌块的制备方法及其在药物合成中的应用 |
| WO2025045837A1 (en) | 2023-08-31 | 2025-03-06 | Syngenta Crop Protection Ag | Pesticidally active indazole compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1291569B1 (it) * | 1997-04-15 | 1999-01-11 | Angelini Ricerche Spa | Indazolammidi come agenti serotoninergici |
| US6069152A (en) * | 1997-10-07 | 2000-05-30 | Eli Lilly And Company | 5-HT4 agonists and antagonists |
| TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| ATE469897T1 (de) * | 2004-12-22 | 2010-06-15 | Theravance Inc | Indazolcarbonsäureamidverbindungen |
| WO2007010390A1 (en) * | 2005-07-22 | 2007-01-25 | Pfizer Japan Inc. | Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| GB0614070D0 (en) * | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| GB0901487D0 (en) * | 2009-01-30 | 2009-03-11 | Movetis N V | Asthma Therapy |
| US9000175B2 (en) * | 2010-11-26 | 2015-04-07 | Lupin Limited | Bicyclic GPR119 modulators |
| DK2758394T3 (en) * | 2011-09-19 | 2015-04-20 | Suven Life Sciences Ltd | HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS |
-
2012
- 2012-06-06 CA CA2833507A patent/CA2833507A1/en not_active Abandoned
- 2012-06-06 BR BR112013030939A patent/BR112013030939A2/pt not_active IP Right Cessation
- 2012-06-06 AU AU2012267797A patent/AU2012267797A1/en not_active Abandoned
- 2012-06-06 WO PCT/JP2012/065052 patent/WO2012169649A1/en not_active Ceased
- 2012-06-06 EP EP12796621.6A patent/EP2718283A4/en not_active Withdrawn
- 2012-06-06 US US14/005,659 patent/US20140057895A1/en not_active Abandoned
- 2012-06-06 CN CN201280025823.9A patent/CN103748087A/zh active Pending
- 2012-06-06 RU RU2013157374/04A patent/RU2013157374A/ru not_active Application Discontinuation
- 2012-06-06 JP JP2013547047A patent/JP2014510708A/ja active Pending
- 2012-06-06 KR KR1020137032070A patent/KR20140041519A/ko not_active Withdrawn
- 2012-06-06 MX MX2013014427A patent/MX2013014427A/es unknown
- 2012-06-07 TW TW101120435A patent/TW201311674A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013157374A (ru) | Производное индазола и пирролопиридина и его фармацевтическое применение | |
| JP2014133739A5 (enExample) | ||
| RU2016133684A (ru) | Бициклические азот-содержащие соединения как агонисты М1 мускариновых рецепторов | |
| RU2396269C2 (ru) | Производные гетероарилзамещенного пиперидина в качестве ингибиторов печеночной карнитин пальмитоилтрансферазы (l-cpt1) | |
| IL258577A (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
| HRP20231310T1 (hr) | Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene | |
| KR101949624B1 (ko) | Tank-결합 키나제 억제제 화합물로서 유용한 아미노트리아진 유도체 | |
| JP2025016684A5 (enExample) | ||
| CA2670760A1 (en) | Naphthyridine compounds as inhibitors of akt activity | |
| JP2022531932A5 (enExample) | ||
| RU2009146851A (ru) | Гетероарил-замещенные пиразольные производные, которые могут использоваться для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом | |
| JP2018535999A5 (enExample) | ||
| RU2016144202A (ru) | АНАЛОГИ СОЕДИНЕНИЙ 4Н-ПИРАЗОЛО[1,5-a]БЕНЗИМИДАЗОЛА В КАЧЕСТВЕ ИНГИБИТОРОВ PARP | |
| JP2013526536A5 (enExample) | ||
| JP2014525448A5 (enExample) | ||
| JP2017510554A5 (enExample) | ||
| AU2018201953A1 (en) | Certain amino-pyridazines, compositions thereof, and methods of their use | |
| JP2011503194A5 (enExample) | ||
| JP2015533157A5 (enExample) | ||
| JP2006502134A5 (enExample) | ||
| JP2014532619A5 (enExample) | ||
| JP2016536333A5 (enExample) | ||
| JP2009526081A5 (enExample) | ||
| JP2017524026A5 (enExample) | ||
| JP2018507235A5 (enExample) |